Literature DB >> 10753321

Idiopathic Subjective Tinnitus Treated by Amitriptyline Hydrochloride/Biofeedback.

.   

Abstract

The efficiency of two treatment modalities for subjective/idiopathic tinnitus (SIT): biofeedback (BF) and amitriptyline hydrochloride (AT) was investigated in 225 randomly selected subjects. Findings show that after 10 weeks of treatment in the BF group, 43.5% of the patients reported an improvement of tinnitus during activity. In the AT group, 27.5% of patients reported subjective improvement of tinnitus at rest although only 15.8% of the AT patients reported improvement during activity. Biofeedback during rest had a significantly better effect on tinnitus disturbance than AT. No objective diminishment of tinnitus loudness was found as a result of any of the treatment modalities. We believe that BF can help tinnitus patients especially during periods of rest and we also suggest trying tricyclic antidepressant drugs such as AT for treatment of tinnitus patients, in small doses, however, to minimize the side effects of this drug. Subjective tinnitus (ST) is one of the most common and yet most unclear of otologic symptoms.(1-4) ST can accompany any type of hearing loss including both sensorineural as well as conductive hearing loss, and may originate from any part of the auditory pathway.(1,5) Treatment of ST must be primarily directed to the basic illness diagnosed after a thorough general ear-nose-throat and neurologic evaluation.(6) Severity of ST is evaluated both objectively, by determining the pitch and intensity of the tinnitus,(7) and subjectively as described by the patient. Because of the relatively high incidence of ST and in some patients, the severe personal reaction to it, many different treatments have been suggested, but generally only small to moderate success has been achieved in reducing tinnitus and its consequences, if any at all.(8) In this study we examined the effect of two treatment modalities: amitriptyline hydro-chloride and biofeedback.

Entities:  

Year:  1995        PMID: 10753321

Source DB:  PubMed          Journal:  Int Tinnitus J        ISSN: 0946-5448


  9 in total

Review 1.  Tinnitus.

Authors:  Julian Savage; Stephanie Cook; Angus Waddell
Journal:  BMJ Clin Evid       Date:  2009-11-12

Review 2.  Antidepressants for patients with tinnitus.

Authors:  Paolo Baldo; Carolyn Doree; Paola Molin; Don McFerran; Sara Cecco
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 3.  Tinnitus.

Authors:  Julian Savage; Angus Waddell
Journal:  BMJ Clin Evid       Date:  2012-02-03

Review 4.  Tinnitus.

Authors:  Julian Savage; Angus Waddell
Journal:  BMJ Clin Evid       Date:  2014-10-20

5.  Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management.

Authors:  Michele Fornaro; Matteo Martino
Journal:  Neuropsychiatr Dis Treat       Date:  2010-06-24       Impact factor: 2.570

Review 6.  Emerging pharmacotherapy of tinnitus.

Authors:  Berthold Langguth; Richard Salvi; Ana Belén Elgoyhen
Journal:  Expert Opin Emerg Drugs       Date:  2009-12       Impact factor: 4.191

Review 7.  The Management and Outcomes of Pharmacological Treatments for Tinnitus.

Authors:  Devon Beebe Palumbo; Kathleen Joos; Dirk De Ridder; Sven Vanneste
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

Review 8.  Auditory Neural Plasticity in Tinnitus Mechanisms and Management.

Authors:  Kunkun Wang; Dongmei Tang; Jiaoyao Ma; Shan Sun
Journal:  Neural Plast       Date:  2020-07-01       Impact factor: 3.599

9.  Tinnitus: characteristics, causes, mechanisms, and treatments.

Authors:  Byung In Han; Ho Won Lee; Tae You Kim; Jun Seong Lim; Kyoung Sik Shin
Journal:  J Clin Neurol       Date:  2009-03-31       Impact factor: 3.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.